Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
New proposal to revise the definition of light-chain smoldering myeloma to abnormal serum FLC values, absence of detectable intact immunoglobulin on SPEP and immunofixation, and BMPC > 10% without myeloma-defining events.”
Title: Redefining light-chain smoldering multiple myeloma: prevalence and progression risk
Authors: Cecilie Velsoe Maeng, Sigrún Thorsteinsdóttir, Jón Þórir Óskarsson, Sæmundur Rögnvaldsson, Thórir Einarsson Long, Christian Brieghel, Morten Nørgaard Andersen, Andri Ólafsson, Ásdís R. Þórðardóttir, Brynjar Viðarsson, Páll T. Önundarson, Bjarni A. Agnarsson, Margrét Sigurðardóttir, Ingunn Þorsteinsdóttir, Ísleifur Ólafsson, Elías Eyþórsson, Ásbjörn Jónsson, Stephen Harding, Ola Landgren, Thorvardur Jon Love, Kirsten Grønbæk, Carsten U. Niemann, Sigurður Y. Kristinsson
You can read the Full Article on Leukemia.
You can find other articles featuring Robert Orlowski on OncoDaily.
